FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes novel thiadiazinones of the general formula (I) where R1 means A; R2 and R3 means H, A; R4 means benzoyl substituted with C1-C6-alkozy-group; R5 means NA2 or saturated five- or six-membered heterocyclic residue with at least one N-atom that can be replaced with A; Q means branched or nonbranched alkylene with 1-10 C-atoms or it is absent; n = 1, 2 or 3; A means alkyl with 1-6 C-atoms, and their physiologically active acceptable salts also. Compounds can be used in treatment of patients with cardiac insufficiency. Invention describes method of synthesis of these compounds and pharmaceutical composition based on thereof also. EFFECT: new compounds indicated above, improved method of synthesis, valuable medicinal properties. 4 cl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SEPARATION OF 5-HETARYL-1,3,4-THIADIAZINONE ENANTIOMERS | 1992 |
|
RU2053231C1 |
ARYLALKYLDIAZINONES, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD OF ITS PREPARING | 1996 |
|
RU2167159C2 |
ARYLALKYLTHIADIAZINONES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2161613C2 |
BICYCLIC AROMATIC AMINO ACIDS | 1998 |
|
RU2187506C2 |
BENZYLPIPERIDINE DERIVATIVES, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND METHOD OF PREPARATION THEREOF | 1995 |
|
RU2160259C2 |
DERIVATIVES OF BENZAMIDINE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2194044C2 |
ARYLALKANOYLPYRIDAZINES | 1997 |
|
RU2201923C2 |
CYCLOPEPTIDE DERIVATIVES | 1997 |
|
RU2202557C2 |
DERIVATIVES OF CHROMENONE AND CHROMANONE AS INTEGRIN INHIBITORS | 1999 |
|
RU2234505C2 |
HETEROCYCLYL-BENZOYLGUANIDINES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2152390C1 |
Authors
Dates
2001-01-20—Published
1996-01-10—Filed